'Designer' Cells for Cellular Immunotherapy: Zinc Finger Nuclease (ZFN) Stimulated Targeted Recombination for the Simultaneous Disruption of the Endogenous Glucocorticoid Receptor and Site-Specific Addition of the IL13-Zetakine

MLA

Matthew C. Mendel, et al. “‘Designer’ Cells for Cellular Immunotherapy: Zinc Finger Nuclease (ZFN) Stimulated Targeted Recombination for the Simultaneous Disruption of the Endogenous Glucocorticoid Receptor and Site-Specific Addition of the IL13-Zetakine.” Blood, vol. 108, Nov. 2006, p. 3705. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........511453ae0e7029700470b6219d3fb3db&authtype=sso&custid=ns315887.

APA

Matthew C. Mendel, Jeffrey C. Miller, Andreas Reik, Dale Ando, Michael C. Jensen, Fyodor D. Urnov, Erica A. Moehle, Edward J. Rebar, Philip D. Gregory, Yuanyue Zhou, Michael C. Holmes, & Pei-Qi Liu. (2006). “Designer” Cells for Cellular Immunotherapy: Zinc Finger Nuclease (ZFN) Stimulated Targeted Recombination for the Simultaneous Disruption of the Endogenous Glucocorticoid Receptor and Site-Specific Addition of the IL13-Zetakine. Blood, 108, 3705.

Chicago

Matthew C. Mendel, Jeffrey C. Miller, Andreas Reik, Dale Ando, Michael C. Jensen, Fyodor D. Urnov, Erica A. Moehle, et al. 2006. “‘Designer’ Cells for Cellular Immunotherapy: Zinc Finger Nuclease (ZFN) Stimulated Targeted Recombination for the Simultaneous Disruption of the Endogenous Glucocorticoid Receptor and Site-Specific Addition of the IL13-Zetakine.” Blood 108 (November): 3705. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........511453ae0e7029700470b6219d3fb3db&authtype=sso&custid=ns315887.